Advancing drug discovery through systems biology

Drug Discovery Today

Volumn 8, Issue 4, 2003, Pages 175-183

  Davidov, Eugene J ^a   Holland, Joanne M ^a   Marple, Edward W ^a   Naylor, Stephen ^a  

^a Beyond Genomics   (United States)

Author keywords

Bioinformatics; Data; Drug discovery; Drug Discovery; Information; Molecular Medicine; Pharmaceutical Science; Systems biology

Indexed keywords

DATA BASE; DRUG INDUSTRY; DRUG MARKETING; GENE INTERACTION; GENOME ANALYSIS; GENOMICS; HUMAN; MEDICAL INFORMATION; MEDICAL TECHNOLOGY; METABOLIC ENGINEERING; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; NONHUMAN; ORGANIZATION; REVIEW; SYSTEM ANALYSIS;

ANIMALS; BIOTECHNOLOGY; COMBINATORIAL CHEMISTRY TECHNIQUES; COMPUTATIONAL BIOLOGY; DRUG DESIGN; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; METABOLISM; PROTEOMICS;

EID: 0037441522     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(03)02600-X     Document Type: Review

References (45)

1. Wess G. How to escape the bottleneck of medicinal chemistry. Drug Discov. Today. 7:2002;533-535.
2. Manly, C.J. (2001) Discovery technologies and the issues facing drug discovery. Curr. Drug Discov. (September), 9-10.
3. Gaudillière B., et al. To market, to market - 2000. Annu. Rep. Med. Chem. 36:2000;293-318.
4. Oprea T.I. Chemical space navigation in lead discovery. Curr. Opin. Chem. Biol. 6:2002;384-389.
5. Schena M., et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 270:1995;467-470.
6. Templin M.F., et al. Protein microarray technology. Trends Biotechnol. 20:2002;160-166.
7. Kuruvilla F.G., et al. Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays. Nature. 416:2002;653-657.
8. Hieter P., Boguski M. Functional genomics: It's all how you read it. Science. 278:1997;601-602.
9. Zheng X.F.S., Chan T-F. Chemical genomics and the global study of protein functions. Drug Discov. Today. 7:2002;197-205.
10. Drews J. Drug discovery: A historical perspective. Science. 287:2000;1960-1964.
11. Wise A., et al. Target validation of G-protein coupled receptors. Drug Discov. Today. 7:2002;235-246.
12. Bonetta L. Systems biology - the new R&D buzzword? Nat. Med. 8:2002;315-316.
13. Weiner N. Cybernetics or Control and Communication in the Animal and Machine. 1948;MIT Press.
14. Bertalanffy L.V. General System Theory, Foundations, Development, Applications. 1969;George Brazziller, New York.
15. Kitano H. Kitano H. Foundations of Systems Biology. 2001;MIT Press.
16. Kitano H. Systems biology: A brief overview. Science. 295:2002;1662-1664.
17. Csete M.E., Doyle J.C. Reverse engineering of biological complexity. Science. 295:2002;1664-1669.
18. Whitfield J. All creatures great and small. Nature. 413:2001;342-344.
19. Freeman M. Feedback control of intercellular signalling in development. Nature. 408:2000;313-319.
20. Milo R., et al. Network motifs: Simple building blocks of complex networks. Science. 298:2002;824-827.
21. Olsson L. An expanded role for microbial physiology in metabolic engineering and functional genomics: Moving towards systems biology. FEMS Yeast Res. 2:2002;175-181.
22. Cascante M., et al. Metabolic control analysis in drug discovery and disease. Nat. Biotechnol. 20:2002;243-249.
23. Sanford K., et al. Genomics to fluxomics and physiomics - pathway engineering. Curr. Opin. Microbiol. 5:2002;318-322.
24. Fiehn O., et al. Metabolite profiling for plant functional genomics. Nat. Biotechnol. 18:2000;1157-1161.
25. Glassbrook N., et al. Metabolic profiling on the right path. Nat. Biotechnol. 18:2000;1142-1143.
26. Raamsdonk L.M., et al. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat. Biotechnol. 19:2001;45-50.
27. Nicholson J.K., et al. Metabonomics': Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 29:1999;1181-1189.
28. Roessner U., et al. Technical advance: Simultaneous analysis of metabolites in potato tuber by gas chromatography-mass spectrometry. Plant J. 23:2000;131-142.
29. Verner J. Large-scale prediction of phenotype: Concept. Biotech. Bioeng. 69:2000;664-678.
30. Burgard A.P., et al. Minimal reaction sets for Escherichia coli metabolism under different growth requirements and uptake environments. Biotechnol. Prog. 17:2001;791-797.
31. Griffin J.L., et al. Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy. FEBS Lett. 530:2002;109.
32. Sikora K. Surrogate endpoints in cancer drug development. Drug Discov. Today. 7:2002;951-956.
33. Butina D., et al. Predicting ADME properties in silico: Methods and models. Drug Discov. Today. 7:(Suppl.):2002;S83-S88.
34. Reo N.V. NMR-based metabolomics. Drug Chem. Toxicol. 25:2002;375-382.
35. Palsson B. The challenges of in silico biology. Nat. Biotechnol. 18:2000;1147-1150.
36. Arkin A.P. Synthetic cell biology. Curr. Opin. Biotechnol. 12:2001;638-644.
37. Somogyi R., Greller L.D. The dynamics of molecular networks: Applications to therapeutic discovery. Drug Discov. Today. 6:2001;1267-1277.
38. Thieffry T.D. Qualitative analysis of gene networks. In "Pacific Symposium on Biocomputing. 1998;77-88 World Scientific Publishers, V.
39. Terret N.K., et al. Sildenafil (Viagra™), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction. Bioorg. Med. Chem. Lett. 6:1996;1819.
40. Capdeville R., et al. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat. Rev. Drug Discov. 1:2002;493-502.
41. Marinissen M.J., Gutkind J.S. G-protein-coupled receptors and signaling networks: Emerging paradigms. Trends Pharmacol. Sci. 22:2001;368-376.
42. Macritchie K.A.N., Young A.H. Emerging targets for the treatment of depressive disorder. Expert Opin. Ther. Targets. 5:2001;601.
43. Ideker T., et al. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science. 292:2001;929-934.
44. Stoll M., et al. A genomic-systems biology map for cardiovascular function. Science. 294:2001;1723-1726.
45. Neumann E., Thomas J. Knowledge assembly for the life sciences. Drug Discov. Today. 7:(Suppl.):2002;S160-S162.